Northrop Grumman (NOC) FY2025 10-K Annual Report

Filed: Jan 27, 2026
Health Care
Search, Detection, Navigation, Guidance, Aeronautical SysSEC EDGAR

Northrop Grumman (NOC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Jan 27, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Northrop Grumman FY2025 10-K Analysis

Business Overview

  • Core aerospace and defense technology provider to U.S. government, focusing on military aircraft, missile defense, space systems, and advanced technologies
  • Realignment of Strike and Surveillance Aircraft Solutions from Defense Systems to Aeronautics Systems effective January 1, 2025
  • Backlog grew to $95.7 billion at Dec 31, 2025, up from $91.5 billion in prior year
  • Workforce expansion with approx. 7,500 new employees hired in 2025, totaling about 95,000 employees
  • 2025 sales split evenly between cost-type ($20.9B) and fixed-price contracts ($21.0B), with 84% revenue from U.S. government

Management Discussion & Analysis

  • Revenue $41.95B, up 2% YoY; organic sales up 3% excluding divested training services ($112M in 2025 vs $304M in 2024)
  • Operating income $4.51B, up 3%; operating margin 10.8% vs 10.6% in 2024
  • Best segment: Mission Systems with $229M higher income; worst: Aeronautics Systems down $423M due to B-21 loss provision
  • Gain on training services divestiture $231M; unallocated corporate expense down due to divestiture; no specific buyback/dividend/capex figures disclosed
  • Management highlights risks from geopolitical tensions, budget uncertainty, and B-21 program losses; expects long-term growth from defense modernization and program restructures

Risk Factors

  • Regulatory risk: potential Nunn-McCurdy Act notifications on cost/schedule overruns may trigger program restructures or terminations impacting reputation and finances
  • Macroeconomic threat: U.S. government funding reliance with 84% sales in 2025 exposes to appropriations delays, shutdowns, or debt ceiling breaches impacting cash flows
  • Operational risk: 50% of sales from fixed-price contracts increase exposure to cost overruns amid inflation, material shortages, and labor challenges affecting profitability
  • Competitive risk: increased competition from commercial contractors, startups, and use of Other Transaction Authority (OTA) awards intensifies pricing pressure and contract risk
  • Legal risk: investigations and audits by DCAA, DCMA, DoW Inspector General may lead to penalties, suspension, or debarment jeopardizing contract awards and revenues

Northrop Grumman FY2025 Key Financial Metrics
XBRL

Revenue

$42.0B

+2.2% YoY

Net Income

$4.2B

+0.2% YoY

Operating Margin

10.8%

+10bp YoY

Net Margin

10.0%

-20bp YoY

ROE

25.1%

-222bp YoY

Total Assets

$51.4B

+4.1% YoY

EPS (Diluted)

$29.08

+2.6% YoY

Operating Cash Flow

$4.8B

+8.4% YoY

Source: XBRL data from Northrop Grumman FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Northrop Grumman

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.